FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, May 12, 2022
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on May 12, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 12, 2022
- Product Type
- Biologics
View Company Profile
ID · ce5076b5-1e62-4a8e-b708-c17c96eee53e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1169330
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Baxter Healthcare Corporation
11| Date | Classification | Office | Project area |
|---|---|---|---|
| August 20, 2026 | Not classified | Atlanta District Office | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 9, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 31, 2023 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 1, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1299166 - 2026-08-20
- FDA Inspection 1230544 - 2024-02-09
- FDA Inspection 1221559 - 2023-10-31
- FDA Inspection 1151566 - 2021-07-01
- FDA Inspection 1031655 - 2017-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.